The use of allogeneic drug "Orgamax" in the treatment of periodontitis
Aim. Examine the clinical efficacy of allogeneic osteoplastic drug «Orgamax» in the treatment of periodontitis of teeth. Materials and methods. The main group consisted of 60 patients (122 channels), which was carried out endodontic treatment with the use of «Argamaks». The second group included 42 patients (92 channels) treated by the traditional method. Before and after treatment, a control x-ray examination and osteodensitometry were carried out. Results. Comparative osteodensitometry, carried out at different times, showed that the use of «Orgamax» in the treatment of destructive forms of chronic periodontitis is 23.8% more effective than the use of traditional drugs based on calcium hydroxide. When using the drug «Orgamax» for the treatment of periodontitis teeth was active regeneration in the focus of destruction with the replacement of the defect with newly formed bone tissue. By the year of 92.9% of patients achieved complete restoration of periapical bone structure. Conclusion. The use of the drug «Orgamax», which has antiseptic, antimicrobial and osteoplastic properties, in the treatment of chronic periodontitis of teeth allows to accelerate the regenerative process in the periapical focus of destruction, to reduce the number of medical manipulations, relapses of inflammation, to improve the efficiency and long-term results of treatment.